Comparison of the cytokine profile in patients with uveitis;Üveitli olgularda sitokin profilinin karşilaştirilmasi

Gulhane Medical Journal

Volumn 48, Issue 3, 2006, Pages 151-156

  Hürmeriç, Volkan ^a   Erdem, Üzeyir ^a   Inal, Ali ^a   Bayraktar, M Zeki ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cytokine; Serum levels; Uveitis

Indexed keywords

EID: 34848893648     PISSN: 13020471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Boyd SR, Young S, Lightman S. Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol 2001; 46: 209-233.
2. Lightman S. Uveitis: what do we know and how does it help? Clin Exp Immunol 2001; 29: 48-51.
3. Nussenblatt R, Whitcup S, Palestine A. Uveitis. Fundementals and Clinical Practice. Chicago: Mosby-Year Book, 1996: 3-10.
4. de Smet MD, Chan CC. Regulation of ocular inflammation-what experimental and human studies have taught us. Prog Retin Eye Res 2001; 20: 761-797.
5. George RK, Chan CC, Whitcup SM, et al. Ocular immunopathology of Behcet's disease. Surv Ophthalmol 1997; 42: 157-162.
6. al-Janadi M, al-Balla S, al-Dalaan A, et al. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13: 58-67.
7. Lacomba SM, Martin MC, Galera GJM, et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 2001; 33: 251-255.
8. Liekfeld A, Schweig F, Jaeckel C, et al. Intraocular antibody production in intraocular inflammation. Graefes Arch Clin Exp Ophthalmol 2000; 238: 222-227.
9. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990; 335: 1078-1080.
10. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987; 103: 234-245.
11. Hamuryudan V, Fresko I, Direskeneli H, et al. Evaluation of the Turkish translation of a disease activity form for Behcet's syndrome. Rheumatology 1999; 38: 734-736.
12. Dick AD. Immune mechanisms of uveitis: insights into disease pathogenesis and treatment. Int Ophthalmol Clin 2000; 40: 1-18.
13. Kim SJ, Zhang M, Vistica BP, et al. Induction of ocular inflammation by T-helper lymphocytes type 2. Invest Ophthalmol Vis Sci 2002; 43: 758-765.
14. Caspi RR, Sun B, Agarwal RK, et al. T cell mechanisms in experimental autoimmune uveoretinitis: susceptibility is a function of the cytokine response profile. Eye 1997; 11: 209-211.
15. Rizzo LV, Miller-Rivero NE, Chan CC, et al. Interleukin-2 treatment potentiates induction of oral tolerance in a murinemodel of autoimmunity. J Clin Invest 1994; 94: 1668-1672.
16. Mege JL, Dilsen N, Sanguedolce V, et al. Overproduction of monocyte derived tumor necrosis factor alpha, İL-6, İL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993; 20: 1544-1549.
17. Kosar A, Haznedaroglu S, Karaaslan Y, et al. Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2,interleukin-2 receptor, and E-selectin in Behcet's disease. Rheumatol Int 1999; 19: 11-14.
18. Lacomba SM, Martin MC, Chamond RR, et al. Aqueous and serum interferon gamma, interleukin 2, İL-4 and İL-10 in patients with uveitis. Arch Ophthalmol 2000; 118: 768-772.
19. Norose K, Yano A, Wang XC, et al. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994; 35: 33-39.
20. Muhaya M, Calder V, Towler HMA, et al. Charecterization of T cells and cytokines in the aques humour in patients with Fuchs' heterochromic cyclitis and idiopathic anterior uveitis. Clin Exp Immunol 1998; 111: 123-128.
21. Mantas C, Direskeneli H, Demiralp E, et al. Serum levels of Th2 cytokines İL-4 and İL-10 in Behçet's Disease. J Rheumatol 1999; 26: 510-512.
22. Martin CM, Lacomba MS, Molina CI, et al. Levels of soluble ICAM-1 and soluble IL-2R in the serum and aqueous humor of uveitis patients. Curr Eye Res 2000; 20: 287-292.
23. Sahin S, Akoglu T, Direskeneli H, et al. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behcet's disease. Ann Rheum Dis 1996; 55: 128-133.
24. Klok AM, Luyendijk L, Zaal MJ, et al. Soluble ICAM-1 serum levels in patients with intermediate uveitis. Br J Ophthalmol 1999; 83: 847-851.
25. De Vos AF, Hoekzema R, Kijlstra A. Cytokines and uveitis, a review. Curr Eye Res. 1992; 11: 581-597.
26. Lee SJ, Li Z, Sherman B, et al. Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1993; 34: 3522-3525.
27. Hamzaoui K, Hamzaoui A, Guemira F, et al. Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol 2002; 31: 205-210.
28. El-Shabrawi Y, Livir-Rallatos C, Christen W, et al. High levels of interleukin-12 in the aqueous humor and vitreous of patients with uveitis. Ophthalmology 1998; 105: 1659-1663.